Uli S. Herrmann
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Corrigendum to "Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains" [Neurobiol. Aging 36 (2015) 1994-2003].
Journal: Neurobiology of aging
Published: September 19, 2024
Eyelid Closure Behavior of Patients with Idiopathic and Nonorganic Hypersomnia, Narcolepsy-Cataplexy, and Healthy Controls in the Maintenance of Wakefulness Test.
Journal: Nature and science of sleep
Published: March 11, 2023
Loss of PIKfyve drives the spongiform degeneration in prion diseases.
Journal: EMBO molecular medicine
Published: June 15, 2021
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.
Journal: Science translational medicine
Published: July 04, 2018
Differential Toxicity of Antibodies to the Prion Protein.
Journal: PLoS pathogens
Published: October 26, 2015
Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss.
Journal: Journal of hepatology
Published: September 22, 2015
Structure-based drug design identifies polythiophenes as antiprion compounds.
Journal: Science translational medicine
Published: August 07, 2015
A neuroprotective role for microglia in prion diseases.
Journal: The Journal of experimental medicine
Published: June 16, 2015
Correction: Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways.
Journal: PLoS pathogens
Published: April 16, 2015
Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.
Journal: Neurobiology of aging
Published: October 29, 2014
Last Updated: 09/26/2026